50242-202 : Evrysdi 5 mg Oral Tablet
| NDC: | 50242-202 |
| Labeler: | Genentech, Inc. |
| Product Type: | Human Prescription Drug |
| Drug Name: | Evrysdi |
| Dosage Form: | Oral Tablet |
| Application #: | NDA219285 |
| Rev. Date: |
NDC Package Codes:
- 50242-202-01: 1 BOTTLE, PLASTIC IN 1 CARTON (50242‑202‑01) / 30 TABLET IN 1 BOTTLE, PLASTIC
Active Ingredients:
- Risdiplam
Dosage Strength:
- 5 mg
Pharmaceutical Classes:
- Increased Protein Synthesis [PE]
- Multidrug and Toxin Extrusion Transporter 1 Inhibitors [MoA]
- Multidrug and Toxin Extrusion Transporter 2 K Inhibitors [MoA]
- Survival of Motor Neuron 2 Splicing Modifier [EPC]
- Survival of Motor Neuron 2 Splicing Modifiers [MoA]
Related Products:
Based on records with the same trade name.- 50242-175 Evrysdi .75 mg/ml Oral Powder, for Solution by Genentech Inc.
NDC QR Code
Scan the QR code below to easily reference this data in the future:
< Prev: 50242-176Next: 50242-210 >
Note: The RxChat NDC Database uses publicly available data from the FDA and the U.S. National Library of Medicine (NLM); The NLM is not responsible for the data presented and does not endorse or recommend this or any other product. While we make every effort to ensure that the information presented is accurate, you should assume that all results are unvalidated. To report any errors or inconsistencies please contact us.